Search Browse Earnings

Tyra Biosciences, Inc. — SlamSEC

Tyra Biosciences, Inc.

Nasdaq:TYRA

Pharmaceutical Preparations·CARLSBAD, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$103.7M

FY 2025

Net Income

-$86.5M

FY 2025

EPS (Diluted)

-$1.51

FY 2025

Stock Price

$33.40

-3.3%

2026-03-09

52W Range

$6.42 – $35.96

P/E Ratio

-22.1x

Market Cap

$1.8B

Cash

$92.0M

FY 2025

Total Debt

—

Net Cash

$92.0M

Enterprise Value

$1.7B

Debt / EBITDA

0.9x

FY 2025

EV / EBITDA

-16.5x

Employees

—